Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.

Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. Abstract Text:

    muthusamy kunnimalaiyaanMuthusamy Kunnimalaiyaan,mary ndiayeMary Ndiaye,herbert chenHerbert Chen,

    BACKGROUND: Medullary thyroid cancer (MTC) cells exhibit frequent activation of the PI3K pathway as evidenced by the presence of hyperactivation of Akt kinases and overexpression of neuroendocrine (NE) markers. We hypothesized that the inhibition of the PI3K pathway in MTC may lead to a reduction in cell growth and NE tumor marker production. METHODS: Human MTC-TT cells were treated with the PI3K inhibitor LY294002 (0-60 micromol/L) for 8 days, and cellular growth was measured. Further, TT cells were treated with nontoxic concentrations of LY294002 for 2 days, and Western blot analyses were performed for phospho-Akt, total Akt, and the NE tumor markers CgA and human achaete-scute homolog1 (ASCL1). RESULTS: Treatment of TT cells with LY294002 significantly suppressed levels of phospho-Akt. Notably, a dose-dependent reduction in cellular proliferation was also observed. Importantly, NE marker production was also reduced. Mechanistically, we show that cell growth inhibition by PI3K inactivation is mediated by apoptosis attributable to an increase in the levels of cleaved poly(ADP-ribose) polymerase and caspase-3. CONCLUSIONS: MTC cell growth and NE marker production appear to depend on activation of the PI3K-signaling cascade. Inhibition of this important signal transduction pathway may lead to a possible therapeutic strategy to treat patients with MTC.

    Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. Publishing Authors By Initials

    m kunnimalaiyaanM Kunnimalaiyaan,m ndiayeM Ndiaye,h chenH Chen,

    For similar neoplasms: neoplasms by site: endocrine gland neoplasms: thyroid neoplasms research abstracts see: neoplasms: neoplasms by site: endocrine gland neoplasms: thyroid neoplasms research

    PUBMED ID PMID:

    MEDLINE DATE:

    Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Surgery

    VOLUME: 140

    Page Numbers: 1009-14; discussion 1014-5

    Journal Abbreviation: Surgery

    ISSN: 0039-6060

    DAY: 1

    MONTH: 11

    YEAR: 2006

    Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 417347

    Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. Keywords Mesh Terms:

    KEYWORDS: Thyroid Neoplasms

    MESH TERMS: pathology

    Chemical & Substance for Abstract: Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. Information

    Substance Name: Caspase 3

    Registry Number: EC 3.4.22.-

    Grant and Affiliation Information for Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.

    AFFILIATION: Department of Surgery, Section of Endocrine Surgery, Endocrine Surgery Research Laboratories, The University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIDDK

    GRANT: R21-DK066169

    ACRONYM: DK

    MEDLINETA: Surgery

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002 Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News